Cardiff Oncology Inc (CRDF) Unusual Options Activity Today

Checking CRDF unusual options activity helps you spot when traders are making outsized bets on Cardiff Oncology Inc before the broader market catches on. Cardiff Oncology Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor CRDF unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching CRDF unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking CRDF unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and CRDF unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers.

The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Catalysts rarely arrive without a footprint, and CRDF unusual options activity is often where that footprint shows up first. Our scanner tracks Cardiff Oncology Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at CRDF unusual options volume on the call side or chasing put sweeps, Cardiff Oncology Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.